Find a Doctor
Has led more than 100 clinical trials in Alzheimer’s and related dementias
Has published more than 70 peer-reviewed journal articles
Anna D. Burke, MD, is the Karsten Solheim for Dementia Research Chair, Medical Director of the Alzheimer’s and Memory Disorders Program, professor of neurology, and Director of Neuropsychiatry at Barrow Neurological Institute. She specializes in geriatric psychiatry and is board certified in psychiatry with a subspecialty certification in geriatric psychiatry by the American Board of Psychiatry and Neurology.
Dr. Burke’s expertise includes the treatment of challenging behavioral and psychiatric disturbances that result from neurological conditions. She is a member of the American Association for Geriatric Psychiatry, the Alzheimer’s Association International Society to Advance Alzheimer’s Research and Treatment, and the Arizona Neuropsychiatric Association.
Dr. Burke received her medical degree from Gdańsk Medical University. She completed her residency training in adult psychiatry at Hartford Hospital’s Institute of Living before completing a geriatric psychiatry fellowship at McLean Hospital, the largest psychiatric teaching hospital of Harvard Medical School.
In addition to her clinical work, Dr. Burke has led numerous clinical trials of investigational drugs, neuromodulation, environmental modifications, prevention methods, and novel neuroimaging techniques for cognitively impaired patients with neurodegenerative disorders.
For more information or to request an appointment, please call (602) 406-6262.
Fax: (602) 406-6261
- Aetna
- AHCCCS (Referral Required)
- Blue Cross Blue Shield
- Blue Cross Blue Shield Third Party
- Cigna
- Commercial Networks
- Government Plans
- Humana
- Market Place Plans (Referral Required)
- Medicare Advantage Plans (Referral Required)
- United Healthcare
- Fellow, Harvard Medical School, McLean Hospital, 2007-2008
- Resident, Hartford Hospital, Institute of Living, General Adult Psychiatry, 2004-2007
- Internship, Mount Sinai School of Medicine, Elmhurst Hospital, 2003-2004
- MD, Gdańsk Medical University, 2000
- American Association for Geriatric Psychiatry
- Alzheimer’s Association International Society to Advance Alzheimer’s Research and Treatment
- American Neuropsychiatric Association
- AZ Business Healthcare Leadership Award
- Phoenix Magazine Top Doc in Psychiatry
Altered resting-state functional connectivity and dynamic network properties in cognitive impairment: an independent component and dominant-coactivation pattern analyses study.
Date: 01/2024
Authors: Maurizio Bergamino, Anna Burke, Marwan N Sabbagh, Richard J Caselli, Leslie C Baxter, Ashley M. Stokes
WarpDrive: Improving spatial normalization using manual refinements.
Date: 01/2024
Authors: Simón Oxenford, Ana Sofía Ríos, Barbara Hollunder, Clemens Neudorfer, Alexandre Boutet, Gavin J B Elias, Jurgen Germann, Aaron Loh, Wissam Deeb, Bryan Salvato, Leonardo Almeida, Kelly D Foote, Robert Amaral, Paul B Rosenberg, David F Tang-Wai, David A Wolk, Anna D Burke, Marwan N Sabbagh, Stephen Salloway, M Mallar Chakravarty, Gwenn S Smith, Constantine G Lyketsos, Michael S Okun, William S Anderson, Zoltan Mari, Francisco A Ponce, Andres Lozano, Wolf-Julian Neumann, Bassam Al-Fatly, Andreas Horn
Optimal deep brain stimulation sites and networks for stimulation of the fornix in Alzheimer's disease
Date: 12/2022
Authors: Ana Sofía Ríos, Simón Oxenford, Clemens Neudorfer, Konstantin Butenko, Ningfei Li, Nanditha Rajamani, Alexandre Boutet, Gavin J. Elias, Jurgen Germann, Aaron Loh, Wissam Deeb, Fuyixue Wang, Kawin Setsompop, Bryan Salvato, Leonardo Brito Almeida, Kelly D. Foote, Robert Amaral, Paul B. Rosenberg, David F. Tang-Wai, David A. Wolk, Anna D. Burke, Stephen Salloway, Marwan N. Sabbagh, M Mallar Chakravarty, Gwenn S. Smith, Constantine G. Lyketsos, Michael S. Okun, William S. Anderson, Zoltan Mari, Francisco A. Ponce, Andres M. Lozano, Andreas Horn
Safety, Tolerability, and Immunogenicity of the ACI-24 Vaccine in Adults With Down Syndrome: A Phase 1b Randomized Clinical Trial
Date: 06/2022
Authors: Michael S. Rafii, Olivier Sol, William C. Mobley, Saskia Delpretti, Brian G. Skotko, Anna D. Burke, Marwan N. Sabbagh, Shauna H. Yuan, Robert A. Rissman, Margaret Pulsifer, Casey Evans, A Carol Evans, Gregory Beth, Nicolas Fournier, Julian A. Gray, Antonio Melo Dos Santos, Valerie Hliva, Marija Vukicevic, Marie Kosco-Vilbois, Johannes Streffer, Andrea Pfeifer, Howard H. Feldman
Longitudinal Assessment of Intravoxel Incoherent Motion Diffusion-Weighted MRI Metrics in Cognitive Decline.
Date: 03/2022
Authors: Maurizio Bergamino, Anna Burke, Leslie C Baxter, Blaise W Baxter, Leslie C. Baxter, Richard J Caselli, Marwan N Sabbagh, Joshua S Talboom, Matthew J Huentelman, Ashley M Stokes, A. Stokes
- English
- Polish
Has led more than 100 clinical trials in Alzheimer’s and related dementias
Has published more than 70 peer-reviewed journal articles
Anna D. Burke, MD, is the Karsten Solheim for Dementia Research Chair, Medical Director of the Alzheimer’s and Memory Disorders Program, professor of neurology, and Director of Neuropsychiatry at Barrow Neurological Institute. She specializes in geriatric psychiatry and is board certified in psychiatry with a subspecialty certification in geriatric psychiatry by the American Board of Psychiatry and Neurology.
Dr. Burke’s expertise includes the treatment of challenging behavioral and psychiatric disturbances that result from neurological conditions. She is a member of the American Association for Geriatric Psychiatry, the Alzheimer’s Association International Society to Advance Alzheimer’s Research and Treatment, and the Arizona Neuropsychiatric Association.
Dr. Burke received her medical degree from Gdańsk Medical University. She completed her residency training in adult psychiatry at Hartford Hospital’s Institute of Living before completing a geriatric psychiatry fellowship at McLean Hospital, the largest psychiatric teaching hospital of Harvard Medical School.
In addition to her clinical work, Dr. Burke has led numerous clinical trials of investigational drugs, neuromodulation, environmental modifications, prevention methods, and novel neuroimaging techniques for cognitively impaired patients with neurodegenerative disorders.
For more information or to request an appointment, please call (602) 406-6262.
Fax: (602) 406-6261
- Aetna
- AHCCCS (Referral Required)
- Blue Cross Blue Shield
- Blue Cross Blue Shield Third Party
- Cigna
- Commercial Networks
- Government Plans
- Humana
- Market Place Plans (Referral Required)
- Medicare Advantage Plans (Referral Required)
- United Healthcare
- Fellow, Harvard Medical School, McLean Hospital, 2007-2008
- Resident, Hartford Hospital, Institute of Living, General Adult Psychiatry, 2004-2007
- Internship, Mount Sinai School of Medicine, Elmhurst Hospital, 2003-2004
- MD, Gdańsk Medical University, 2000
- American Association for Geriatric Psychiatry
- Alzheimer’s Association International Society to Advance Alzheimer’s Research and Treatment
- American Neuropsychiatric Association
- AZ Business Healthcare Leadership Award
- Phoenix Magazine Top Doc in Psychiatry
Altered resting-state functional connectivity and dynamic network properties in cognitive impairment: an independent component and dominant-coactivation pattern analyses study.
Date: 01/2024
Authors: Maurizio Bergamino, Anna Burke, Marwan N Sabbagh, Richard J Caselli, Leslie C Baxter, Ashley M. Stokes
WarpDrive: Improving spatial normalization using manual refinements.
Date: 01/2024
Authors: Simón Oxenford, Ana Sofía Ríos, Barbara Hollunder, Clemens Neudorfer, Alexandre Boutet, Gavin J B Elias, Jurgen Germann, Aaron Loh, Wissam Deeb, Bryan Salvato, Leonardo Almeida, Kelly D Foote, Robert Amaral, Paul B Rosenberg, David F Tang-Wai, David A Wolk, Anna D Burke, Marwan N Sabbagh, Stephen Salloway, M Mallar Chakravarty, Gwenn S Smith, Constantine G Lyketsos, Michael S Okun, William S Anderson, Zoltan Mari, Francisco A Ponce, Andres Lozano, Wolf-Julian Neumann, Bassam Al-Fatly, Andreas Horn
Optimal deep brain stimulation sites and networks for stimulation of the fornix in Alzheimer's disease
Date: 12/2022
Authors: Ana Sofía Ríos, Simón Oxenford, Clemens Neudorfer, Konstantin Butenko, Ningfei Li, Nanditha Rajamani, Alexandre Boutet, Gavin J. Elias, Jurgen Germann, Aaron Loh, Wissam Deeb, Fuyixue Wang, Kawin Setsompop, Bryan Salvato, Leonardo Brito Almeida, Kelly D. Foote, Robert Amaral, Paul B. Rosenberg, David F. Tang-Wai, David A. Wolk, Anna D. Burke, Stephen Salloway, Marwan N. Sabbagh, M Mallar Chakravarty, Gwenn S. Smith, Constantine G. Lyketsos, Michael S. Okun, William S. Anderson, Zoltan Mari, Francisco A. Ponce, Andres M. Lozano, Andreas Horn
Safety, Tolerability, and Immunogenicity of the ACI-24 Vaccine in Adults With Down Syndrome: A Phase 1b Randomized Clinical Trial
Date: 06/2022
Authors: Michael S. Rafii, Olivier Sol, William C. Mobley, Saskia Delpretti, Brian G. Skotko, Anna D. Burke, Marwan N. Sabbagh, Shauna H. Yuan, Robert A. Rissman, Margaret Pulsifer, Casey Evans, A Carol Evans, Gregory Beth, Nicolas Fournier, Julian A. Gray, Antonio Melo Dos Santos, Valerie Hliva, Marija Vukicevic, Marie Kosco-Vilbois, Johannes Streffer, Andrea Pfeifer, Howard H. Feldman
Longitudinal Assessment of Intravoxel Incoherent Motion Diffusion-Weighted MRI Metrics in Cognitive Decline.
Date: 03/2022
Authors: Maurizio Bergamino, Anna Burke, Leslie C Baxter, Blaise W Baxter, Leslie C. Baxter, Richard J Caselli, Marwan N Sabbagh, Joshua S Talboom, Matthew J Huentelman, Ashley M Stokes, A. Stokes
- English
- Polish